<DOC>
	<DOCNO>NCT00861861</DOCNO>
	<brief_summary>The purpose study compare effect pitavastatin atorvastatin adiponectin percentage change patient hypercholesteremia comorbid stable CAD .</brief_summary>
	<brief_title>Comparison Pitavastatin With Atorvastatin Increasing High Density Lipoprotein - Cholesterol ( HDL-C ) Adiponectin Patients With Dyslipidemia Coronary Artery Disease ( CAD )</brief_title>
	<detailed_description>The efficiency lipid lower therapy already proven clinical trial statin . According result , target value LDL-C recommend 100mg/dL Japan Atherosclerosis Society Guidelines . However , efficiency intensive therapy lower LDL-C 100mg/dL proven yet .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Patients dyslipidemia define parameter : HDLC &lt; 50 mg/dL LDLC ≥ 140 mg/dL LDLC ≥ 100 mg/dL cholesterollowering treatment necessary accordance investigator 's judgement Patients pass three month acute myocardial infarction Patients pass one month unstable angina Patients pass one month PCI Patients write consent volition provide sufficient explanation participation clinical trial Patients allergy pitavastatin atorvastatin Patients familial hypercholesterolemia Patients receive pitavastatin Patients severe hypertension Patients renal disorder undergoing dialysis Patients hepatobiliary disorder Patients hepatobiliary disorder Patients family history hypothyroidism muscular dystrophy Patients history druginduced hepatic disorder Drug abuser dipsomaniac Patients cardiogenic shock . Patients hop pregnancy study Contraindications , Relative Contraindications , Absolute Contraindications Coadministration Relative Contraindications Coadministration pitavastatin atorvastatin Patients ineligible opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Pitavastatin</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>CAD</keyword>
	<keyword>HDL-C</keyword>
	<keyword>Adiponectin</keyword>
</DOC>